Coyne Terrance P.

CIK 00018148761 companyNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001814876

Recent Transactions

20 trades

Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-12-01$39.87/sh−65,832→ 592,492 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-12-01$39.87/sh−3,750→ 47,260 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-12-01$39.87/sh−65,832→ 592,492 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-12-01$39.87/sh−3,750→ 47,260 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-11-24$38.67/sh−55,146→ 669,010 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-11-24$37.96/sh−10,686→ 658,324 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-11-24$38.67/sh−3,126→ 51,634 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-11-24$37.96/sh−624→ 51,010 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-11-24$38.67/sh−55,146→ 669,010 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-11-24$37.96/sh−10,686→ 658,324 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-11-24$38.67/sh−55,146→ 669,010 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-11-24$37.96/sh−624→ 51,010 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-11-24$38.67/sh−55,146→ 669,010 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-11-24$37.96/sh−10,686→ 658,324 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-11-24$38.67/sh−3,126→ 51,634 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-11-24$37.96/sh−624→ 51,010 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-11-24$38.67/sh−3,126→ 51,634 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-11-24$37.96/sh−10,686→ 658,324 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-11-24$38.67/sh−3,126→ 51,634 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-11-24$37.96/sh−624→ 51,010 total

Companies

Royalty Pharma plc
EVP & CFO
$RPRX

Recent Filings

Address

C/O ROYALTY PHARMA PLC 110 EAST 59TH STREET

NEW YORK, NY, 10022

View on SEC.gov